公开(公告)号：WO2023059900A2

公开(公告)日：2023-04-13

申请号：PCT/US2022/046089

申请日：2022-10-07

Applicant: INVIVYD, INC.

Inventor： DABORA, Rebecca ,  RATNASWAMY, Gayathri ,  MARTIN-MOE, Sheryl ,  MANNING, Mark, Cornell ,  HOLCOLM, Ryan

IPC: C07K16/10 ,  A61K39/42

Abstract: The present disclosure is directed to pharmaceutical formulations comprising antibodies, and antigen binding fragments thereof, having binding specificity for the S protein of coronaviruses (CoV-S). Other embodiments of the disclosure include the use of pharmaceutical formulations for the diagnosis, assessment, and treatment of diseases and disorders associated with coronaviruses, or the S protein thereof, and conditions where neutralization or inhibition of coronaviruses, or the S protein thereof, would be therapeutically and/or prophylactically beneficial.